Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
ANDREW PELLER LIMITED	ADW.A	Toronto S.E. +2 Other	16,984	3.87 CAD	Stock
ANDREW PELLER LIMITED	ANJ	Deutsche Boerse AG	-	2.62 EUR
ANDREW PELLER LIMITED	ADWPF	OTC Markets	1,056	2.85 USD
ANDREW YULE & COMPANY LIMITED	ANDREWYU	Bombay S.E. +1 Other	251,801	38.54 INR	Stock
ANDREW YULE & COMPANY LIMITED	ANDREWYU	NSE India S.E.	2,260,302	31.35 INR
ANDREW PELLER LIMITED	ADW.B	Toronto S.E.	863	4.71 CAD	Stock
ANDREW YULE & CO. LTD.		NSE India S.E.	0	31.35 INR	Stock

News (104)

JBS S A : MANAGEMENT’S PROPOSAL FOR THE ANNUAL AND EXTRAORDINARY SHAREHOLDERS’ MEETING TO BE HELD ON APRIL 26, 2024 - Form 6-K	29/03	PU
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting	27/03	BU
Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners	05/12	BU
Takeda Pharmaceutical : Notice of Resolutions	28/23/28	PU
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting	30/23/30	BU
BeautyHealth’s Hydrafacial and Prestige Skincare Brand Omorovicza Announce Global Launch of Advanced Skin Renewal Booster	21/23/21	BU
BeautyHealth's Hydrafacial Launches New Booster Developed with BABOR Laboratories in Germany	08/22/08	AQ
BeautyHealth’s Hydrafacial Launches New Booster Developed with BABOR Laboratories in Germany	07/22/07	BU
Takeda Pharmaceutical : Announces New Assignments of Directors - Form 6-K	29/22/29	PU
Takeda Pharmaceutical : Announces New Assignments of Directors	29/22/29	PU
HydraFacial, A BeautyHealth Company, Partners with JLo Beauty to Launch the Revolutionary HydraFacial x JLo Beauty Booster	11/22/11	BU
Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners	05/22/05	BU
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting	01/22/01	BU
Transcript : Takeda Pharmaceutical Company Limited - Shareholder/Analyst Call	11/22/11
General Announcement::Takeda Announces New Assignments of Directors	29/21/29	PU
Takeda Pharmaceutical : Norimasa Takeda Chief Accounting Officer and Corporate Controller (Form 6-K)	29/21/29	PU
Takeda Pharmaceutical : Announces New Assignments of Directors (Form 6-K)	29/21/29	PU
Takeda Announces New Assignments of Directors	29/21/29	CI
Takeda Pharmaceutical : Announces New Assignments of Directors	29/21/29	PU
Endpoints News presents its annual (and once again virtual) R&D Summit: June 14-16	01/21/01	PR
Transcript : Takeda Pharmaceutical Company Limited, Q4 2021 Earnings Call, May 11, 2021	11/21/11
Feiyu Technology International : (1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES (2) PROPOSED GRANTING OF RSU PLAN II ANNUAL MANDATE TO ISSUE NEW SHARES (3) PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND (4) NOTICE OF ANNUAL GENERAL MEETING	22/21/22	PU
Takeda Pharmaceutical : Announces Candidates for New Directors	31/21/31	PU
Transcript : Takeda Pharmaceutical Company Limited, Q3 2021 Earnings Call, Feb 04, 2021	04/21/04
Orphazyme A/S : End of stabilization period	04/20/04	AQ
Orphazyme A/S : End of stabilization period	04/20/04	AQ
End of stabilization period	04/20/04	GL
Transcript : Takeda Pharmaceutical Company Limited, Q2 2021 Earnings Call, Oct 29, 2020	29/20/29
GlaxoSmithKline : To Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding With Its Biggest Competitors	24/20/24	DJ
Orphazyme A/S : Stabilization period begins	29/20/29	AQ
Orphazyme A/S : Stabilization period begins	29/20/29	AQ
Stabilization period begins	29/20/29	GL
China data mystery prompts talk of stealth PBOC bond buying	13/20/13	RE
Transcript : Takeda Pharmaceutical Company Limited, Q1 2021 Earnings Call, Jul 31, 2020	31/20/31
Transcript : Takeda Pharmaceutical Company Limited, Q1 2021 Earnings Call, Jul 31, 2020	31/20/31
Takeda Pharmaceutical : and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners	08/20/08	BU
Takeda Announces New Assignments of Directors	24/20/24	CI
Takeda Pharmaceutical : Announces New Assignments of Directors	24/20/24	PU
Transcript : Takeda Pharmaceutical Company Limited, 2020 Earnings Call, May 13, 2020	13/20/13
Transcript : Takeda Pharmaceutical Company Limited, 2019 Earnings Call, May 13, 2020	13/20/13
Guest blog: Current challenges and opportunities for arbitration in MENA	17/20/17	PU
Transcript : Takeda Pharmaceutical Company Limited, Q3 2020 Earnings Call, Feb 04, 2020	04/20/04
Transcript : Takeda Pharmaceutical Company Limited, Q3 2020 Earnings Call, Feb 04, 2020	04/20/04
Transcript : Takeda Pharmaceutical Company Limited, Q1 2020 Earnings Call, Jul 31, 2019	31/19/31
Takeda Pharmaceutical : Announces New Assignments of Directors	28/19/28	PU

123NextSee all

Companies (22)

ESTEE LAUDER 47 330 M $

The Estée Lauder Companies Inc. is one of the 1st world cosmetics groups. Products are sold under brands (Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le La ...

ESTEE LAUDER 47 330 M $

FLOWERKIST SKIN CARE AND COSMETICS, INC. 2 M $

Flowerkist Skin Care and Cosmetics, Inc. is primarily engaged in providing cannabidiol (CBD) skincare and cosmetics products. It also offers non-invasive body contouring products. The Company offers a range of products, including Botanical Brightening Ser ...

ANDREWS SYKES GROUP PLC 317 M $

Andrews Sykes Group plc is a specialist hire company. The principal activity of the Company is the hire, sale, and installation of a range of equipment, including pumping, portable heating, air conditioning, drying and ventilation equipment. It provides p ...

FEIYU TECHNOLOGY INTERNATIONAL COMPANY LTD. 63 M $

Feiyu Technology International Co., Ltd. is an investment holding company principally engaged in the development and operation of mobile games and Web games. The Companyâs principal markets include both domestic market and overseas markets, including Ho ...

BOHAE BREWERY CO., LTD. 50 M $

BOHAE BREWERY Co., Ltd. is a Korea-based company mainly engaged in the manufacture and sale of liquors. The Companyâs products portfolio consists of Soju, which is a kind of Korean distilled spirits, plum wines, raspberry wines, rice wines, fruit wines, ...

CIPHER MINING INC. 1 153 M $

Cipher Mining Inc. is a technology company. The Company is focused on the development and operation of bitcoin mining data centers. The Company, through its subsidiaries, including Cipher Mining Technologies Inc., operates four bitcoin mining data centers ...

THE GPT GROUP 5 413 M $

The GPT Group is an Australia-based vertically integrated diversified property company that owns and actively manages a portfolio of Australian retail, office and logistics assets, with assets under management of approximately $32.2 billion. The Company u ...

CIRCLE ENERGY, INC. 2 M $

Circle Energy, Inc. was formed for the purpose of acting as an independent exploration and production company to engage in oil and natural gas development, production, acquisition, and exploration activities focused on Texas. It has acquired a 75% working ...

HIROSHIMA GAS CO.,LTD. 168 M $

HIROSHIMA GAS CO., LTD. is a Japan-based company principally engaged in gas business. The Company operates in two business segments. Its Gas segment is engaged in the manufacture, supply and sale of gas, mainly in the Hiroshima Prefecture. Its Gas segment ...

123Next

Insiders

Andrew Plump

Andrew S. Plump occupies the position of Director, Research & Development President at Takeda Pharmaceutical Co., Ltd. and Vice President for Takeda Pharmaceuticals International, Inc. (a subsidiary of Takeda Pharmaceutical Co., Ltd.). He is also Vice President of Takeda Pharmaceuticals International, Inc. In his past career he held the position of Vice President-Research & Translational Medicine at Sanofi and Vice President-Cardiovascular Disease Franchise at Merck & Co., Inc. Andrew S. Plump received a doctorate from the University of California, a doctorate from The Rockefeller University and an undergraduate degree from Massachusetts Institute of Technology.

Jim Plump

Jim Plump currently works as a Director for the Japan-America Society of Indiana.

No results for this search